Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers
Open Access
- 13 January 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 21 (6) , 503-512
Abstract
Identifying the biological basis of smoking cessation success is of growing interest. The rate of nicotine metabolism, measured by the nicotine metabolite ratio, affects multiple aspects of nicotine dependence. Fast nicotine metabolizers tend to smoke more, experience more withdrawal and craving, and have lower cessation rates compared with slow metabolizers. The nicotine metabolite ratio predicts treatment response, and differences in brain activation between fast metabolizers and slow metabolizers have been reported in fMRI studies. As reinforcing/rewarding effects of tobacco are associated with dopamine transmission, the purpose of the present study was to study the dopaminergic system in human smokers based on their nicotine metabolite ratio. The first aim of the study was to explore if there were differences in D2 and D3 receptor binding between fast metabolizers and slow metabolizers during abstinence. The second aim was to explore smoking-induced dopamine release in both groups. Participants underwent 2 [11C]-(+)-PHNO PET scans: one scan during abstinence and the other after smoking a tobacco cigarette. Subjective measures were recorded and blood was drawn for measurement of nicotine and cotinine levels. During abstinence, slow metabolizers (n = 13) had lower [11C]-(+)-PHNO binding potential than fast metabolizers (n = 15) restricted to the D2 regions of the associative striatum and sensorimotor striatum. After smoking a cigarette, [11C]-(+)-PHNO binding potential was decreased in the limbic striatum and ventral pallidum, suggestive of increases in dopamine, but there were no nicotine metabolite ratio differences. Further studies are required to delineate if differences in [11C]-(+)-PHNO binding between slow metabolizers and fast metabolizers at abstinence baseline are preexisting traits or induced by prolonged tobacco use.Keywords
Funding Information
- National Institutes of Health (R21DA039453)
This publication has 56 references indexed in Scilit:
- Advances in the neurobiological bases for food ‘liking’ versus ‘wanting’Physiology & Behavior, 2014
- CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokersPharmacogenetics and Genomics, 2013
- Higher Binding of the Dopamine D3Receptor-Preferring Ligand [11C]-(+)-Propyl-Hexahydro-Naphtho-Oxazin in Methamphetamine Polydrug Users: A Positron Emission Tomography StudyJournal of Neuroscience, 2012
- Smoking-induced change in intrasynaptic dopamine concentration: Effect of treatment for Tobacco DependencePsychiatry Research: Neuroimaging, 2010
- Ventral Striatal Dopamine Release in Response to Smoking a Regular vs a Denicotinized CigaretteNeuropsychopharmacology, 2008
- The Role ofCYP2A6in the Emergence of Nicotine Dependence in AdolescentsPediatrics, 2007
- The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]racloprideSynapse, 2004
- Smoking-Induced Ventral Striatum Dopamine ReleaseAmerican Journal of Psychiatry, 2004
- Nicotine metabolite ratio as a predictor of cigarette consumptionNicotine & Tobacco Research, 2003
- Slower Metabolism and Reduced Intake of Nicotine From Cigarette Smoking in Chinese-AmericansJNCI: Journal of the National Cancer Institute, 2002